Epidural Steroid Injections Reviewed for Radicular Pain, Spinal Stenosis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 21, 2025 -- There is some evidence for epidural steroid injections (ESIs) reducing pain and disability in cervical and lumbar radiculopathies and possibly in lumbar spinal stenosis, according to a study published online Feb. 12 in Neurology.
Carmel Armon, M.D., from Loma Linda University School of Medicine in California, and colleagues conducted a systematic review to evaluate the use of ESIs in cervical and lumbar spinal stenosis and radiculopathies. Due to the variability in efficacy measures, differences based on any measure of success were reported as the success rate difference (SRD).
Ninety randomized controlled trials met the inclusion criteria. The researchers found that ESIs probably reduced short-term pain (SRD, −24.0 percent; number needed to treat [NNT], 4) and disability (SRD, −16.0 percent; NNT, 6) and possibly reduced long-term disability (SRD, −11.1 percent; NNT, 9) in cervical and lumbar radiculopathies. The evidence was insufficient to determine whether ESIs reduced long-term pain in radiculopathies. ESIs possibly reduced short-term (SRD, −26.2 percent; NNT, 4) and long-term (SRD, −11.8 percent; NNT, 8) disability in lumbar spinal stenosis, but there was no reduction in short-term pain; insufficient evidence was seen for determining whether ESIs reduced long-term pain. The evidence was insufficient for determining the effectiveness of ESIs in cervical spinal stenosis.
"The systematic review found evidence that ESIs are probably effective in reducing short-term pain and disability caused by radiculopathy and possibly effective in reducing short-term disability, but not pain, in lumbar spinal stenosis," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-22 06:00
Read more
- Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
- Tranexamic Acid Can Prevent Postpartum Hemorrhage in Women With Placenta Previa After C-Section
- A Single Dose of Lilly's PCSK9 Base Editor, VERVE-102, Reduced PCSK9 by up to 88% and LDL-C by up to 62%, with Durable Effects Supporting its Potential as a One-Time Treatment for Hypercholesterolemia
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- Migraine With Aura Linked to Incident Ischemic Stroke Risk in Those 45 Years and Older
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions